Aetna's Board Set To Approve $68 Billion Sale To CVS Health

Aetna's board of directors was meeting on Sunday to approve the U.S. health insurer’s sale to U.S. drugstore chain operator CVS Health Corp for approximately $207 per share in cash and stock. The $68 billion deal will be this year’s largest corporate acquisition. It will combine one of the nation’s largest pharmacy benefits managers and pharmacy operators with one of its oldest health insurers, whose far-reaching business ranges from employer healthcare to government plans nationwide.